The underlying hypothesis suggests that TKIs induce the conversion of a nonimmunogenic ‘cold’ tumor into an inflamed ‘hot’ tumor by blocking MAPK, Wnt-β-catenin, CDK4-CDK6 or PTEN-dependent signaling pathways (33). The gene discussed is CDK6; the disease is neoplasm.